Recent significant positive changes in fundamentals have benefitted JinkoSolar Holding Co Ltd (NYSE: JKS): the consensus estimate for December, 2024 increased significantly, the consensus estimate for December, 2023 increased significantly, and significant quarterly earnings acceleration […]
Graham Corp (NYSE: GHM) has reported earnings for its second fiscal quarter (ending September 30) of $0.04 versus a loss $-0.02 for the same period a year ago. For the latest four quarters through September […]
Granite Construction Inc. (NYSE: GVA) has recently enjoyed extremely important positive changes in investment behavior: the stock’s recent price rise disrupted its longer term downtrend, its longer term price trend turned up, and its shorter […]
For its first fiscal quarter (ending September 30), Alpha and Omega Semiconductor Li (NASDAQ: AOSL) has reported a -78% decline in E.P.S. from $0.95 a year ago to $0.21 in the current quarter. This result […]
Dril-Quip Inc. (NYSE: DRQ) has recently experienced exceptional negative changes in fundamentals: the stock’s power rating fell below 50, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus […]
For its third fiscal quarter (ending September 30), CNO Financial Group Inc (NYSE: CNO) has reported a -4% decline in E.P.S. from $1.54 a year ago to $1.48 in the current quarter. Relative to the […]
CoreCivic Inc (NYSE: CXW) has reported E.P.S. of $0.12 for its third fiscal quarter (ending September 30) versus $0.59 for the same period a year ago — a decline of -80%. Relative to the consensus […]
JAKKS Pacific Inc (NASDAQ: JAKK) has benefited from extremely meaningful positive changes in investment behavior: its longer term price trend turned up, the stock’s recent price rise disrupted its longer term downtrend, positive upside/downside volume […]
For its fourth fiscal quarter (ending September 30), Cabot Corp (NYSE: CBT) has reported a 148% increase in E.P.S. from $1.65 a year ago to $4.10 in the current quarter. This performance was $2.62 better […]
Myriad Genetics Inc (NASDAQ: MYGN) has reported E.P.S. of $-0.75 for its third fiscal quarter (ending September 30) versus $-0.43 for the same period a year ago. Relative to the consensus estimate of $-0.08, this […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research